Neurological Advocacy

Abstract

Advocacy is an important part of the practice of neurology integral to optimal patient care and research. Opportunities exist for neurologists to further their engagement in advocacy outside of the office, and neurologists are well-positioned to share their knowledge and expertise as advocates. Many barriers to care, such as the cost of and access to prescription drugs, have an outsized impact on patients with neurological conditions, which underscores the importance of neurological advocacy. Advocacy opportunities span many different forms and range from local to global in scale. The benefits to a neurology career can be vast, from improved knowledge of health care systems to leadership opportunities, to networking among colleagues and community leaders, and enhanced academic profiles. Numerous resources are available for neurologists seeking further engagement in advocacy for their patients and profession.

Keywords

advocacy - advocate - public policy - neurology - neurological disease

Publication History

Article published online:
16 May 2025

• References

• 1 Earnest MA, Wong SL, Federico SG. Perspective: physician advocacy: what is it and how do we do it?. Acad Med 2010; 85 (01) 63-67
• 2 American Medical Association. Code of medical ethics. Accessed January 13, 2025 at: https://code-medical-ethics.ama-assn.org/
• 3 Epilepsy Foundation. Kentucky 'Teens Speak Up!' ambassador helps pass legislation to support students with epilepsy. Updated August 20, 2018. Accessed January 13, 2025 at: https://www.epilepsy.com/stories/kentucky-teens-speak-ambassador-helps-pass-legislation-support-students-epilepsy
• 4 Colino S. Epilepsy advocates work to make schools seizure safe. Brain & Life. February/March 2023. Accessed January 13, 2025 at: https://www.brainandlife.org/articles/epilepsy-advocates-make-schools-seizure-safe
• 5 World Federation of Neurology. The vital roles of the neurologist and advocacy. Accessed January 13, 2025 at: https://wfneurology.org/activities/brain-health-initiative/vital-roles-of-the-neurologist-and-advocacy
• 6 Wasay M, Grisold W, Wijeratne T, Struhal W, Younis S. World Federation of Neurology. The future of brain health advocacy: recommendations of the 2023 World Congress of Neurology advocacy panel. J Neurol Sci 2024; 458: 122914
• 7 Grisold W, Struhal W, Grisold T. eds. Advocacy in Neurology. Oxford; 2019. online edition, Oxford Academic, March 1, 2019. https://doi.org/10.1093/med/9780198796039.001.0001
• 8 GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024; 23 (04) 344-381
• 9 Feigin VL, Vos T, Nichols E. et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 2020; 19 (03) 255-265
• 10 Gusovsky AV, Lin CC, Kerber K, Reynolds EL, Callaghan BC, Burke JF. Costs are still on the rise for commonly prescribed branded neurologic medications. Neurology 2024; 103 (10) e210029
• 11 Rosendale N. Social determinants of health in neurology. Neurol Clin 2022; 40 (01) 231-247
• 12 Levine DA, Duncan PW, Nguyen-Huynh MN, Ogedegbe OG. Interventions targeting racial/ethnic disparities in stroke prevention and treatment. Stroke 2020; 51 (11) 3425-3432
• 13 Raffaelli B, Rubio-Beltrán E, Cho SJ. et al. Health equity, care access and quality in headache - part 2. J Headache Pain 2023; 24 (01) 167
• 14 Michaelson NM, Watsula A, Bakare-Okpala A, Mohamadpour M, Chukwueke UN, Budhu JA. Disparities in neuro-oncology. Curr Neurol Neurosci Rep 2023; 23 (12) 815-825
• 15 Gotlieb EG, Blank L, Willis AW, Agarwal P, Jette N. Health equity integrated epilepsy care and research: a narrative review. Epilepsia 2023; 64 (11) 2878-2890
• 16 Giesser BS, Kanof M. Neuro-advocacy-professionalism in action. JAMA Neurol 2022; 79 (01) 7-8
• 17 Quorum. State legislatures vs Congress: which is more productive? Accessed January 13, 2025 at: https://www.quorum.us/data-driven-insights/state-legislatures-versus-congress-which-is-more-productive/#:~:text=States%20Introduce%20More%20Legislation%20Than,introduced%20between%20January%20and%20June.
• 18 Narayanaswami P, Showers D, Levi B. et al. State neurologic societies and the AAN: strengthening neurology for the future. Neurol Clin Pract 2014; 4 (03) 247-255
• 19 American Academy of Neurology. Advocacy toolkit for neurology: how to be an advocate. Accessed January 13, 2025 at: https://www.aan.com/advocacy/advocacy-toolkit
• 20 Wijeratne T, DePold Hohler A. Residency training: advocacy training in neurology: lessons from the Palatucci Advocacy Leadership Forum. Neurology 2013; 80 (01) e1-e3
• 21 Brender TD, Plinke W, Arora VM, Zhu JM. Prevalence and characteristics of advocacy curricula in U.S. medical schools. Acad Med 2021; 96 (11) 1586-1591
• 22 Verma S, Flynn L, Seguin R. Faculty's and residents' perceptions of teaching and evaluating the role of health advocate: a study at one Canadian university. Acad Med 2005; 80 (01) 103-108
• 23 Abuzinadah AR, Cooke L. Neurology health advocacy curriculum: needs assessment, curricular content, and underlying components. Can J Neurol Sci 2017; 44 (02) 170-176
• 24 Wright CJ, Moreno MA, Katcher ML, McIntosh GC, Mundt MP, Corden TE. Development of an advocacy curriculum in a pediatric residency program. Teach Learn Med 2005; 17 (02) 142-148
• 25 Schwarz K, Sisk B, Schreiber J, Malik F. A common thread: pediatric advocacy training. Pediatrics 2015; 135 (01) 7-9
• 26 Nerlinger AL, Shah AN, Beck AF. et al. The advocacy portfolio: a standardized tool for documenting physician advocacy. Acad Med 2018; 93 (06) 860-868
• 27 Epilepsy Foundation. Seizure safe schools. Accessed January 13, 2025 at: https://www.epilepsy.com/sites/default/files/2022-10/Seizure_Safe_Schools_Position_Statement_October2022.pdf